Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer

Abstract Purpose Microsatellite high instability/deficient mismatch repair (MSI-H/dMMR) colorectal cancer (CRC) has an active tumor microenvironment, rendering it more sensitive to immune checkpoint inhibitors. Given that studies involving patients with MSI-H colorectal cancer with RAS mutations are...

Full description

Saved in:
Bibliographic Details
Main Authors: Yupeng Jiang, Yuyao Liu, Hong Huang, Tiantian Zhao, Zengyi Zhao, Yawen Gao
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-024-03926-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571649712455680
author Yupeng Jiang
Yuyao Liu
Hong Huang
Tiantian Zhao
Zengyi Zhao
Yawen Gao
author_facet Yupeng Jiang
Yuyao Liu
Hong Huang
Tiantian Zhao
Zengyi Zhao
Yawen Gao
author_sort Yupeng Jiang
collection DOAJ
description Abstract Purpose Microsatellite high instability/deficient mismatch repair (MSI-H/dMMR) colorectal cancer (CRC) has an active tumor microenvironment, rendering it more sensitive to immune checkpoint inhibitors. Given that studies involving patients with MSI-H colorectal cancer with RAS mutations are scarce, we explored the effect of RAS mutations on the TME in patients with MSI-H/dMMR cancer and identified potential prognostic factors. Methods Seventy-five patients diagnosed with MSI-H/dMMR colorectal cancer were retrospectively enrolled and divided into RAS-mutant and -wild-type groups. The expression levels of CD11c+ dendritic cells, CD4+ T cells, CD8+ T cells, and regulatory T cell (Treg) markers were detected, and prognostic factors were analyzed. Results RAS-mutant MSI-H colorectal patients were more likely to have: (1) higher platelet values; (2) shorter disease-free survival (DFS); (3) lower infiltrated numbers of CD11c+ dendritic cells, CD4+ T lymphocytes, and CD8+ T lymphocytes, and higher infiltrated numbers of Foxp3+ Treg cells. In MSI-H/dMMR CRC patients: (1) the high CD11c + , CD4 +,  and CD8 +  cells infiltration group had longer DFS than the low-infiltration group, and Foxp3 + cells infiltration was not significantly correlated with DFS; (2) the RAS mutation status, number of CD11c+ cells infiltrated, and carbohydrate antigen 19–9 (CA19–9) level were the potential prognostic factors. Conclusion RAS mutations in patients with MSI-H/dMMR CRC may reduce the infiltration of CD11c+ dendritic cells, CD4+ T cells, and CD8+ T cells, and increase the infiltration of Foxp3+ Treg cells to affect the tumor microenvironment of patients. RAS gene status, CD11c + cells infiltration, and CA19–9 level were potential prognostic factors for MSI-H/dMMR CRC.
format Article
id doaj-art-470db0eadf01471fb547041677f30e06
institution Kabale University
issn 1432-0851
language English
publishDate 2025-02-01
publisher Springer
record_format Article
series Cancer Immunology, Immunotherapy
spelling doaj-art-470db0eadf01471fb547041677f30e062025-02-02T12:26:15ZengSpringerCancer Immunology, Immunotherapy1432-08512025-02-0174311410.1007/s00262-024-03926-9Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancerYupeng Jiang0Yuyao Liu1Hong Huang2Tiantian Zhao3Zengyi Zhao4Yawen Gao5Department of Oncology, The Second Xiangya Hospital, Central South UniversityDepartment of Oncology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South ChinaGuilin Medical UniversityDepartment of Oncology, The Second Xiangya Hospital, Central South UniversityDepartment of Oncology, The Second Xiangya Hospital, Central South UniversityDepartment of Oncology, The Second Xiangya Hospital, Central South UniversityAbstract Purpose Microsatellite high instability/deficient mismatch repair (MSI-H/dMMR) colorectal cancer (CRC) has an active tumor microenvironment, rendering it more sensitive to immune checkpoint inhibitors. Given that studies involving patients with MSI-H colorectal cancer with RAS mutations are scarce, we explored the effect of RAS mutations on the TME in patients with MSI-H/dMMR cancer and identified potential prognostic factors. Methods Seventy-five patients diagnosed with MSI-H/dMMR colorectal cancer were retrospectively enrolled and divided into RAS-mutant and -wild-type groups. The expression levels of CD11c+ dendritic cells, CD4+ T cells, CD8+ T cells, and regulatory T cell (Treg) markers were detected, and prognostic factors were analyzed. Results RAS-mutant MSI-H colorectal patients were more likely to have: (1) higher platelet values; (2) shorter disease-free survival (DFS); (3) lower infiltrated numbers of CD11c+ dendritic cells, CD4+ T lymphocytes, and CD8+ T lymphocytes, and higher infiltrated numbers of Foxp3+ Treg cells. In MSI-H/dMMR CRC patients: (1) the high CD11c + , CD4 +,  and CD8 +  cells infiltration group had longer DFS than the low-infiltration group, and Foxp3 + cells infiltration was not significantly correlated with DFS; (2) the RAS mutation status, number of CD11c+ cells infiltrated, and carbohydrate antigen 19–9 (CA19–9) level were the potential prognostic factors. Conclusion RAS mutations in patients with MSI-H/dMMR CRC may reduce the infiltration of CD11c+ dendritic cells, CD4+ T cells, and CD8+ T cells, and increase the infiltration of Foxp3+ Treg cells to affect the tumor microenvironment of patients. RAS gene status, CD11c + cells infiltration, and CA19–9 level were potential prognostic factors for MSI-H/dMMR CRC.https://doi.org/10.1007/s00262-024-03926-9RAS mutationHigh microsatellite instabilityDeficient mismatch repairColorectal cancerTumor microenvironment
spellingShingle Yupeng Jiang
Yuyao Liu
Hong Huang
Tiantian Zhao
Zengyi Zhao
Yawen Gao
Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
Cancer Immunology, Immunotherapy
RAS mutation
High microsatellite instability
Deficient mismatch repair
Colorectal cancer
Tumor microenvironment
title Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
title_full Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
title_fullStr Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
title_full_unstemmed Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
title_short Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
title_sort effect of ras mutations and related immune characteristics on the prognosis of patients with msi h dmmr colorectal cancer
topic RAS mutation
High microsatellite instability
Deficient mismatch repair
Colorectal cancer
Tumor microenvironment
url https://doi.org/10.1007/s00262-024-03926-9
work_keys_str_mv AT yupengjiang effectofrasmutationsandrelatedimmunecharacteristicsontheprognosisofpatientswithmsihdmmrcolorectalcancer
AT yuyaoliu effectofrasmutationsandrelatedimmunecharacteristicsontheprognosisofpatientswithmsihdmmrcolorectalcancer
AT honghuang effectofrasmutationsandrelatedimmunecharacteristicsontheprognosisofpatientswithmsihdmmrcolorectalcancer
AT tiantianzhao effectofrasmutationsandrelatedimmunecharacteristicsontheprognosisofpatientswithmsihdmmrcolorectalcancer
AT zengyizhao effectofrasmutationsandrelatedimmunecharacteristicsontheprognosisofpatientswithmsihdmmrcolorectalcancer
AT yawengao effectofrasmutationsandrelatedimmunecharacteristicsontheprognosisofpatientswithmsihdmmrcolorectalcancer